Aadi Bioscience, Inc. AADI | $4.33M | 7.53 | 1.85M | 0% | +$0 | 2.81 | |
Taysha Gene Therapies, Inc. TSHA | $9.57M | 1.78 | 3.33M | -7.13% | -$734,720.02 | 6.22 | |
Mersana Therapeutics, Inc. MRSN | $9.7M | 1.77 | 2.16M | -8.59% | -$911,106.52 | 6.3 | |
Ocular Therapeutix, Inc. OCUL | $23.98M | 1.7 | 2.64M | +101.17% | +$12.06M | 15.58 | |
Tourmaline Bio, Inc. TRML | $5.98M | 1.02 | 261,108 | +12.6% | +$669,275.38 | 3.89 | |
Praxis Precision Medicines, Inc. PRAX | $9.9M | 0.95 | 162,302 | -45.83% | -$8.38M | 6.44 | |
Leap Therapeutics, Inc. LPTX | $942,082.00 | 0.93 | 354,166 | 0% | +$0 | 0.61 | |
Enliven Therapeutics, Inc. ELVN | $6.97M | 0.84 | 396,099 | +219.75% | +$4.79M | 4.53 | |
Verastem, Inc. VSTM | $2.44M | 0.82 | 207,095 | -10.83% | -$296,817.20 | 1.59 | |
Terns Pharmaceuticals, Inc. TERN | $3.05M | 0.72 | 465,079 | -16.24% | -$591,587.31 | 1.98 | |
Applied Therapeutics, Inc. APLT | $5.39M | 0.69 | 792,000 | +50.83% | +$1.81M | 3.5 | |
HilleVax, Inc. HLVX | $4.17M | 0.5 | 250,609 | -22.8% | -$1.23M | 2.71 | |
Cellectar Biosciences, Inc. CLRB | $571,130.00 | 0.4 | 143,500 | -69.95% | -$1.33M | 0.37 | |
Rocket Pharmaceuticals, Inc. RCKT | $8.8M | 0.36 | 326,787 | -10.72% | -$1.06M | 5.72 | |
Viridian Therapeutics, Inc. VRDN | $3.49M | 0.31 | 199,433 | -29.15% | -$1.44M | 2.27 | |
Disc Medicine, Inc. IRON | $4.78M | 0.31 | 76,800 | -33.51% | -$2.41M | 3.11 | |
Mereo BioPharma Group plc MREO | $1.31M | 0.28 | 397,884 | New | +$1.31M | 0.85 | |
Lyra Therapeutics, Inc. LYRA | $1.08M | 0.28 | 173,320 | New | +$1.08M | 0.7 | |
Dyne Therapeutics, Inc. DYN | $5.24M | 0.19 | 184,500 | +24.8% | +$1.04M | 3.4 | |
Celldex Therapeutics, Inc. CLDX | $4.57M | 0.17 | 109,000 | +57.06% | +$1.66M | 2.97 | |
ORIC Pharmaceuticals, Inc. ORIC | $1.43M | 0.15 | 103,992 | New | +$1.43M | 0.93 | |
Kura Oncology, Inc. KURA | $1.92M | 0.12 | 90,000 | -87.17% | -$13.04M | 1.25 | |
Crinetics Pharmaceuticals, Inc. CRNX | $3.67M | 0.1 | 78,403 | -10.4% | -$425,830.52 | 2.38 | |
Agios Pharmaceuticals, Inc. AGIO | $1.62M | 0.1 | 55,262 | New | +$1.62M | 1.05 | |
Vaxcyte, Inc. PCVX | $7.16M | 0.1 | 104,830 | -10.69% | -$856,812.29 | 4.65 | |
Revolution Medicines, Inc. RVMD | $4.63M | 0.09 | 143,777 | -10.14% | -$522,867.32 | 3.01 | |
Sarepta Therapeutics, Inc. SRPT | $8.31M | 0.07 | 64,162 | -9.12% | -$833,463.53 | 5.4 | |
Arcellx, Inc. ACLX | $2.4M | 0.06 | 34,500 | -55.2% | -$2.96M | 1.56 | |
Immunovant, Inc. IMVT | $2.98M | 0.06 | 92,346 | -22.72% | -$876,990.25 | 1.94 | |
Insmed Incorporated INSM | $1.67M | 0.04 | 61,718 | +109.21% | +$874,074.16 | 1.09 | |
Ultragenyx Pharmaceutical Inc. RARE | $933,800.00 | 0.02 | 20,000 | New | +$933,800.00 | 0.61 | |
Intra-Cellular Therapies, Inc. ITCI | $920,360.00 | 0.01 | 13,300 | New | +$920,360.00 | 0.6 |